TY  - JOUR
AU  - Gridelli, Cesare
AU  - Ciuleanu, Tudor
AU  - Domine, Manuel
AU  - Szczesna, Aleksandra
AU  - Bover, Isabel
AU  - Cobo, Manuel
AU  - Kentepozidis, Nikolaos
AU  - Zarogoulidis, Konstantinos
AU  - Kalofonos, Charalabos
AU  - Kazarnowisz, Andrzej
AU  - Korozan, Magdalena
AU  - de-Las-Penas, Ramon
AU  - Majem, Margarita
AU  - Chella, Antonio
AU  - Griesinger, Frank
AU  - Bournakis, Evangelos
AU  - Sadjadian, Parvis
AU  - Kotsakis, Athanasios
AU  - Chinet, Thierry
AU  - Syrigos, Kostantinos N
AU  - Correale, Pierpaolo
AU  - Gallou, Catherine
AU  - Jamet, Jeanne- Menez
AU  - Vetsika, Eleni- Kyriaki
AU  - Kosmatopoulos, Kostas
AU  - Georgoulias, Vassilis
PY  - 2020
DO  - 10.1038/s41416-020-0785-y
UR  - http://hdl.handle.net/10668/15282
T2  - British journal of cancer
AB  - The cancer vaccine Vx-001, which targets the universal tumour antigen TElomerase Reverse Transcriptase (TERT), can mount specific Vx-001/TERT572 CD8 + cytotoxic T cells; this immune response is associated with improved overall survival (OS) in...
LA  - en
PB  - Nature Publishing Group
KW  - CD8-Positive T-Lymphocytes
KW  - Cancer Vaccines
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Aged
KW  - Female
KW  - Humans
KW  - Immunity
KW  - Immunotherapy
KW  - Maintenance Chemotherapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Placebo Effect
KW  - Telomerase
TI  - Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
TY  - research article
VL  - 122
ER  -